Impact Factor 2021: 3.041 (@Clarivate Analytics)
5-Year Impact Factor: 2.776 (@Clarivate Analytics)
Immediacy Index: 0.927
Impact Factor Rank: 10/24, Q2 (Tropical Medicine)
  • Users Online: 382
  • Print this page
  • Email this page
This article has been cited by
1A new coumarin based Schiff base fluorescence probe for zinc ion
Busra Arvas,Burcu Ucar,Tayfun Acar,Melih Besir Arvas,Yucel Sahin,Feray Aydogan,Cigdem Yolacan
Tetrahedron.2021;88()132127
[DOI]
2In Vitro Evaluation of Immunogenicity of Recombinant OMP25 Protein Obtained from Endemic Brucella abortus Biovar 3 as Vaccine Candidate Molecule Against Animal Brucellosis
Tugba Atabey,Tayfun Acar,Serap Derman,Emel Ordu,Aysegül Erdemir,Pakize Neslihan Tasli,Günseli Kurt Gür,Fikrettin Sahin,Medine Güllüce,Tülin Arasoglu
Protein & Peptide Letters.2021;28(10)1138
[DOI]
3Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis
Ozlem Ayse Tosyali,Adil Allahverdiyev,Melahat Bagirova,Emrah Sefik Abamor,Mehmet Aydogdu,Sahar Dinparvar,Tayfun Acar,Zeynep Mustafaeva,Serap Derman
Materials Science and Engineering: C.2021;120(10)111684
[DOI]
4Nano-co-delivery of lipophosphoglycan with soluble and autoclaved leishmania antigens into PLGA nanoparticles: Evaluation of in vitro and in vivo immunostimulatory effects against visceral leishmaniasis
Pragya Misra,Shailza Singh
Materials Science and Engineering: C.2020;120(10)1
[DOI]
5Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease - An update overview
João Paulo Assolini,Amanda Cristina Machado Carloto,Bruna Taciane da Silva Bortoleti,Manoela Daiele Gonçalves,Fernanda Tomiotto Pellissier,Paulo Emilio Feuser,Arthur Poester Cordeiro,Pedro Henrique Hermes de Araújo,Claudia Sayer,Milena Menegazzo Miranda Sapla,Wander Rogério Pavanelli
European Journal of Pharmacology.2022;923(10)174934
[DOI]
6A Chimera of Th1 Stimulatory Proteins of Leishmania donovani Offers Moderate Immunotherapeutic Efficacy with a Th1-Inclined Immune Response against Visceral Leishmaniasis
Sneha Ratnapriya,Sneha Keerti,Narendra Kumar Yadav,Anuradha Dube,Amogh Anant Sahasrabuddhe,Washington L. C. dos Santos
BioMed Research International.2021;2021(10)1
[DOI]